First GLP-1 implant approval in the EU by 2030 Q1

A regulatory agency in the European Union will grant market authorization to Vivani Medical’s semaglutide implant for weight maintenance therapy by March 31, 2030. This would mark the first approved GLP-1 implant globally, validating the technology’s viability.

regulatory · Prediction Market

Implied probability (Yes)

35%

Closes

2030-03-31

More regulatory markets

• UK government increases teacher pay offer by 2%+ in 2027 — 45% Yes
• FIFA issues formal disciplinary action against Trump by 2026-12-31 — 70% Yes
• UK government to allocate £200M for river clean-up by 2026 — 70% Yes
• FIFA issues formal reprimand against U.S. Soccer for Trump interference — 75% Yes
• Trump administration implements AI guardrails by Q4 2026 — 70% Yes
• FIFA reinstates Balogun suspension within 30 days — 70% Yes
• Mississippi will revoke xAI's turbine loophole by Q4 2026 — 75% Yes
• Forge Global secures Anthropic approval within 6 months — 75% Yes

Browse all regulatory markets →